Ana C. Ward
Geen lopende functies
Profiel
Ana C.
Ward formerly worked at Yum! Brands, Inc., as Senior Intellectual Property Counsel, Asuragen, Inc., as Senior Vice President & General Counsel from 2010 to 2015, Rosetta Genomics Ltd., as Executive VP-Legal & Corporate Development, Ovid Therapeutics, Inc., as Senior Vice President & General Counsel from 2017 to 2019, Sidley & Austin, as Associate, Ambion, Inc., as General Counsel from 2003 to 2015, Mirna Therapeutics, Inc., as Senior Vice President & General Counsel from 2003 to 2015, and AptamiR Therapeutics, Inc., as Chief Operating Officer.
Ms. Ward received her undergraduate degree, graduate degree, and Masters Business Admin degree from The University of Texas at Austin, graduate degree from The Johns Hopkins University, and doctorate degree from The University of Texas School of Law.
Eerdere bekende functies van Ana C. Ward
| Bedrijven | Functie | Einde |
|---|---|---|
| OVID THERAPEUTICS INC. | Operationeel Directeur | - |
Asuragen, Inc.
 Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Algemeen Adviseur | 01-01-2015 |
Ambion, Inc.
 Ambion, Inc. Pharmaceuticals: MajorHealth Technology Ambion, Inc. develops and supplies RNA based life science research and molecular biology products. It specializes in the development of products for stabilizing, synthesizing, handling, isolating, storing, detecting and measuring RNA. The company was founded in November 1988 and is headquartered in Austin, TX | Algemeen Adviseur | 01-01-2015 |
Mirna Therapeutics, Inc.
 Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | Algemeen Adviseur | 01-01-2015 |
AptamiR Therapeutics, Inc.
 AptamiR Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services AptamiR Therapeutics, Inc. develops a revolutionary treatment for human obesity. The private company is based in Naples, FL. The company was founded by Marc Thibonnier. | Operationeel Directeur | - |
Opleiding van Ana C. Ward
| The University of Texas at Austin | Graduate Degree |
| The University of Texas School of Law | Doctorate Degree |
| The Johns Hopkins University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| YUM! BRANDS, INC. | Consumer Services |
| ROSETTA GENOMICS LTD. | Health Technology |
| OVID THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Asuragen, Inc.
Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Health Technology |
| Sidley & Austin | Commercial Services |
Ambion, Inc.
Ambion, Inc. Pharmaceuticals: MajorHealth Technology Ambion, Inc. develops and supplies RNA based life science research and molecular biology products. It specializes in the development of products for stabilizing, synthesizing, handling, isolating, storing, detecting and measuring RNA. The company was founded in November 1988 and is headquartered in Austin, TX | Health Technology |
Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | Commercial Services |
AptamiR Therapeutics, Inc.
AptamiR Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services AptamiR Therapeutics, Inc. develops a revolutionary treatment for human obesity. The private company is based in Naples, FL. The company was founded by Marc Thibonnier. | Commercial Services |